Table 5.
G1 | G2 | Total | ||
---|---|---|---|---|
N | % | |||
Surgerya+SRLsb | 7 | 2 | 9 | 45.0 |
Surgery+ratiotherapy+SRLs | 2 | 1 | 3 | 15.0 |
SRLs+cabergoline | 1 | 2 | 3 | 15.0 |
Surgery+radiotherapy+SRLs+cabergoline | 0 | 1 | 1 | 5.0 |
SRLs | 2 | 0 | 2 | 10.0 |
Surgery | 0 | 1 | 1 | 5.0 |
Surgery+radiotherapy | 0 | 1 | 1 | 5.0 |
a: transphenoidal surgery
b: SRLs= somatostatin receptor ligands.